Variant report

Variant	nsv884699
Chromosome Location	chr6:32052983-32064265
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:54)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:54 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr6:32055415..32056027-chr6:32212392..32213271,2	K562	blood:
2	chr6:32045514..32051935-chr6:32052128..32056129,8	K562	blood:
3	chr12:76953385..76954311-chr6:32055413..32056323,2	Hela-S3	cervix:
4	chr6:32059508..32062050-chr6:32079301..32081478,2	MCF-7	breast:
5	chr6:32059497..32061488-chr6:32092582..32095370,2	MCF-7	breast:
6	chr6:32055340..32058127-chr6:32063942..32066027,3	K562	blood:
7	chr6:31938515..31940456-chr6:32053945..32055702,2	K562	blood:
8	chr6:32064150..32065913-chr6:32067334..32070007,2	MCF-7	breast:
9	chr6:32053492..32055184-chr6:32056738..32058324,2	K562	blood:
10	chr6:32053888..32055567-chr6:32183546..32185956,2	K562	blood:
11	chr6:32053956..32056826-chr6:32072906..32074777,2	MCF-7	breast:
12	chr6:32056633..32059100-chr6:32059995..32062239,2	K562	blood:
13	chr6:32055257..32055947-chr6:32122088..32122648,2	MCF-7	breast:
14	chr6:32014907..32017683-chr6:32052613..32055269,2	K562	blood:
15	chr6:32055274..32057139-chr6:32149171..32151292,2	K562	blood:
16	chr6:32064017..32066231-chr6:32074762..32078350,3	MCF-7	breast:
17	chr6:32056041..32058875-chr6:32097399..32098998,2	K562	blood:
18	chr6:32058665..32061404-chr6:32161816..32164497,2	MCF-7	breast:
19	chr6:32036434..32038995-chr6:32053785..32055662,3	K562	blood:
20	chr6:32053535..32057900-chr6:32072309..32076772,5	K562	blood:
21	chr6:32053381..32056427-chr6:32118776..32122445,3	K562	blood:
22	chr6:32055867..32058200-chr6:32115205..32116807,2	K562	blood:
23	chr6:32054200..32056084-chr6:32161547..32163057,2	MCF-7	breast:
24	chr6:32058797..32061105-chr6:32062395..32064272,2	K562	blood:
25	chr6:32059558..32061503-chr6:32079599..32081252,2	K562	blood:
26	chr6:32062411..32068035-chr6:32071225..32076032,7	K562	blood:
27	chr6:32062504..32064653-chr6:32162468..32164378,2	MCF-7	breast:
28	chr6:32052020..32055921-chr6:32094080..32097644,4	MCF-7	breast:
29	chr6:32056633..32059100-chr6:32059995..32062239,2	K562	blood:
30	chr6:32049311..32051554-chr6:32056762..32058610,2	K562	blood:
31	chr6:32054056..32057331-chr6:32057850..32061178,3	MCF-7	breast:
32	chr6:32055104..32055637-chr6:32764487..32765142,2	K562	blood:
33	chr6:32054029..32056254-chr6:32143969..32146934,2	MCF-7	breast:
34	chr6:32054009..32055656-chr6:32135813..32138585,2	K562	blood:
35	chr6:32063507..32065636-chr6:32074118..32076005,2	K562	blood:
36	chr6:32058797..32061105-chr6:32062395..32064272,2	K562	blood:
37	chr6:32055340..32058127-chr6:32063942..32066027,3	K562	blood:
38	chr6:32041144..32041741-chr6:32053347..32053967,2	K562	blood:
39	chr6:32053492..32055184-chr6:32056738..32058324,2	K562	blood:
40	chr6:32056294..32059203-chr6:32162208..32163953,2	MCF-7	breast:
41	chr6:32015682..32016585-chr6:32054909..32055897,3	MCF-7	breast:
42	chr6:32061294..32062977-chr6:32072980..32074692,2	MCF-7	breast:
43	chr6:32053242..32055256-chr6:32141535..32143478,2	K562	blood:
44	chr6:32053794..32056002-chr6:32145307..32147114,2	K562	blood:
45	chr6:32052690..32055339-chr6:32120933..32123433,2	MCF-7	breast:
46	chr6:32052017..32060033-chr6:32072251..32079944,10	K562	blood:
47	chr6:32063250..32065966-chr6:32163442..32165168,2	K562	blood:
48	chr6:32053956..32056565-chr6:32061189..32063571,2	K562	blood:
49	chr6:32053956..32056565-chr6:32061189..32063571,2	K562	blood:
50	chr6:32054056..32057331-chr6:32057850..32061178,3	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000213676	chromatin interactions
ENSG00000204344	chromatin interactions
ENSG00000252512	chromatin interactions
ENSG00000091039	chromatin interactions
ENSG00000168477	chromatin interactions
ENSG00000204315	chromatin interactions
ENSG00000204305	chromatin interactions
ENSG00000258388	chromatin interactions
ENSG00000213654	chromatin interactions
ENSG00000221988	chromatin interactions
ENSG00000204348	chromatin interactions
ENSG00000204308	chromatin interactions
ENSG00000204301	chromatin interactions
ENSG00000204314	chromatin interactions
ENSG00000204310	chromatin interactions

Extended variants
information (count: 339 )
Associated
traits (count: 138 )

Variant overlapped rSNPs/rCNVs (count:339 , 50 per page) page: 1 2 3 4 5 6 7

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs169496	chr6:32052983-32052984	Weak transcription Bivalent Enhancer Enhancers Strong transcription Bivalent/Poised TSS Genic enhancers	Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs531500905	chr6:32053021-32053022	Weak transcription Bivalent Enhancer Enhancers Strong transcription Flanking Bivalent TSS/Enh Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
3	rs543764684	chr6:32053036-32053037	Weak transcription Bivalent Enhancer Enhancers Strong transcription Flanking Bivalent TSS/Enh Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
4	rs568932265	chr6:32053100-32053101	Weak transcription Bivalent Enhancer Enhancers Strong transcription Flanking Bivalent TSS/Enh Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
5	rs9368705	chr6:32053129-32053130	Weak transcription Bivalent Enhancer Enhancers Strong transcription Flanking Bivalent TSS/Enh Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
6	rs117587226	chr6:32053162-32053163	Weak transcription Bivalent Enhancer Enhancers Strong transcription Flanking Bivalent TSS/Enh Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
7	rs192082996	chr6:32053191-32053192	Weak transcription Bivalent Enhancer Enhancers Strong transcription Flanking Bivalent TSS/Enh Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
8	rs117781239	chr6:32053202-32053203	Weak transcription Enhancers Strong transcription Bivalent Enhancer Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
9	rs534132438	chr6:32053327-32053328	Weak transcription Enhancers Strong transcription Bivalent Enhancer Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
10	rs555353776	chr6:32053331-32053332	Weak transcription Enhancers Strong transcription Bivalent Enhancer Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
11	rs116496054	chr6:32053343-32053344	Weak transcription Enhancers Strong transcription Bivalent Enhancer Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
12	rs547119132	chr6:32053393-32053394	Weak transcription Enhancers Strong transcription Bivalent Enhancer Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
13	rs556238472	chr6:32053439-32053440	Weak transcription Bivalent Enhancer Enhancers Strong transcription Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
14	rs145061705	chr6:32053451-32053452	Weak transcription Bivalent Enhancer Enhancers Strong transcription Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
15	rs538746108	chr6:32053485-32053486	Weak transcription Bivalent Enhancer Enhancers Strong transcription Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
16	rs199737284	chr6:32053527-32053528	Weak transcription Bivalent Enhancer Enhancers Strong transcription Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
17	rs200322894	chr6:32053637-32053638	Enhancers Bivalent Enhancer Weak transcription Strong transcription Flanking Active TSS Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
18	rs373054105	chr6:32053680-32053681	Enhancers Bivalent Enhancer Weak transcription Strong transcription Flanking Active TSS Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
19	rs572326271	chr6:32053681-32053682	Enhancers Bivalent Enhancer Weak transcription Strong transcription Flanking Active TSS Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
20	rs372167278	chr6:32053694-32053695	Enhancers Bivalent Enhancer Weak transcription Strong transcription Flanking Active TSS Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
21	rs201292165	chr6:32053695-32053696	Enhancers Bivalent Enhancer Weak transcription Strong transcription Flanking Active TSS Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
22	rs183834630	chr6:32053699-32053700	Enhancers Bivalent Enhancer Weak transcription Strong transcription Flanking Active TSS Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
23	rs138850364	chr6:32053728-32053729	Enhancers Bivalent Enhancer Weak transcription Strong transcription Flanking Active TSS Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
24	rs369219469	chr6:32053729-32053730	Enhancers Bivalent Enhancer Weak transcription Strong transcription Flanking Active TSS Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
25	rs199569974	chr6:32053730-32053731	Enhancers Bivalent Enhancer Weak transcription Strong transcription Flanking Active TSS Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
26	rs377379714	chr6:32053743-32053744	Enhancers Bivalent Enhancer Weak transcription Strong transcription Flanking Active TSS Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
27	rs200771983	chr6:32053748-32053749	Enhancers Bivalent Enhancer Weak transcription Strong transcription Flanking Active TSS Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
28	rs565476717	chr6:32053753-32053754	Enhancers Bivalent Enhancer Weak transcription Strong transcription Flanking Active TSS Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
29	rs533102292	chr6:32053772-32053773	Enhancers Bivalent Enhancer Weak transcription Strong transcription Flanking Active TSS Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
30	rs551174904	chr6:32053793-32053794	Enhancers Bivalent Enhancer Weak transcription Strong transcription Flanking Active TSS Genic enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
31	rs560124416	chr6:32053823-32053824	Bivalent Enhancer Enhancers Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Strong transcription	Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
32	rs527266818	chr6:32053837-32053838	Bivalent Enhancer Enhancers Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Strong transcription	Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
33	rs549278424	chr6:32053846-32053847	Bivalent Enhancer Enhancers Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Strong transcription	Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
34	rs140665128	chr6:32053864-32053865	Bivalent Enhancer Enhancers Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Strong transcription	Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
35	rs374813351	chr6:32053903-32053904	Bivalent Enhancer Enhancers Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Strong transcription	Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
36	rs537743111	chr6:32053915-32053916	Bivalent Enhancer Enhancers Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Strong transcription	Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
37	rs189198753	chr6:32053922-32053923	Bivalent Enhancer Enhancers Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Strong transcription	Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
38	rs571092447	chr6:32053929-32053930	Bivalent Enhancer Enhancers Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Strong transcription	Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
39	rs539149545	chr6:32053973-32053974	Bivalent Enhancer Enhancers Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Strong transcription	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
40	rs553946005	chr6:32053984-32053985	Bivalent Enhancer Enhancers Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Strong transcription	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
41	rs572419950	chr6:32054008-32054009	Bivalent Enhancer Enhancers Weak transcription Genic enhancers Strong transcription	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
42	rs536211365	chr6:32054018-32054019	Bivalent Enhancer Enhancers Weak transcription Genic enhancers Strong transcription	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
43	rs143741175	chr6:32054051-32054052	Bivalent Enhancer Enhancers Weak transcription Genic enhancers Strong transcription	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
44	rs555066175	chr6:32054055-32054056	Bivalent Enhancer Enhancers Weak transcription Genic enhancers Strong transcription	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
45	rs576854807	chr6:32054131-32054132	Bivalent Enhancer Enhancers Weak transcription Genic enhancers Strong transcription	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
46	rs544119036	chr6:32054193-32054194	Bivalent Enhancer Enhancers Weak transcription Genic enhancers Strong transcription	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
47	rs565668643	chr6:32054197-32054198	Bivalent Enhancer Enhancers Weak transcription Genic enhancers Strong transcription	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
48	rs2239688	chr6:32054212-32054213	Bivalent Enhancer Enhancers Genic enhancers Flanking Bivalent TSS/Enh Weak transcription Strong transcription Flanking Active TSS	Chromatin interactive region	10 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs545113133	chr6:32054287-32054288	Bivalent Enhancer Enhancers Genic enhancers Flanking Bivalent TSS/Enh Weak transcription Strong transcription Flanking Active TSS	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a
50	rs529779095	chr6:32054295-32054296	Bivalent Enhancer Enhancers Genic enhancers Flanking Bivalent TSS/Enh Weak transcription Strong transcription Flanking Active TSS	Chromatin interactive region	10 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:138)

Disease	PMID	Source
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Melanoma	18172304	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ovarian cancer	21781307	CNVD
Ependymoma	19289631	CNVD
Breast cancer	22844521	CNVD
Gestational infection	22844521	CNVD
HIV/AIDS	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
abnormal development	18461090	CNVD
Melanoma	17363583	CNVD
Breast cancer	16397240	CNVD
Retinoblastoma	22278416	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Systemic lupus erythematosus	20877625	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Systemic lupus erythematosus	19279649	CNVD
Retinoblastoma	16790693	CNVD
Acute myocardial infarction	18032375	CNVD
Renal cell carcinoma	19150565	CNVD
Systemic lupus erythematosus	19591781	CNVD
Attention deficit hyperactivity disorder	19287146	CNVD
Autism	19287146	CNVD
Erythema nodosum in leprosy	19287146	CNVD
Henoch-schoenlein purpura	19287146	CNVD
Liver cirrhosis	19287146	CNVD
Systemic lupus erythematosus	19287146	CNVD
Congenital adrenal hyperplasia	18478071	CNVD
Systemic lupus erythematosus	19287147	CNVD
Osteosarcoma	16790693	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
Cancer	22183965	CNVD
Melanoma	22183965	CNVD
Myelofibrosis	22110671	CNVD
Incontinentia Pigmenti	22033527	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Encephalopathy	20692195	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	19812545	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD

Chromatin state (count:567 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:32038200-32055000	Weak transcription	Left Ventricle	heart
2	chr6:32041400-32054200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
3	chr6:32044000-32053400	Weak transcription	Fetal Intestine Large	intestine
4	chr6:32045200-32053600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
5	chr6:32046600-32053000	Strong transcription	Fetal Intestine Small	intestine
6	chr6:32046800-32054200	Genic enhancers	Fetal Muscle Trunk	muscle
7	chr6:32049400-32053000	Weak transcription	Brain Cingulate Gyrus	brain
8	chr6:32049400-32059600	Weak transcription	Aorta	Aorta
9	chr6:32049600-32053600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
10	chr6:32050000-32053000	Strong transcription	Fetal Stomach	stomach
11	chr6:32050400-32053400	Weak transcription	Colon Smooth Muscle	Colon
12	chr6:32050400-32053600	Weak transcription	Colonic Mucosa	Colon
13	chr6:32050800-32055000	Weak transcription	Right Atrium	heart
14	chr6:32051000-32053000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
15	chr6:32051000-32053200	Weak transcription	Rectal Smooth Muscle	rectum
16	chr6:32051200-32053200	Weak transcription	Duodenum Mucosa	Duodenum
17	chr6:32051200-32054200	Weak transcription	Pancreas	Pancrea
18	chr6:32051400-32053600	Weak transcription	NHLF	lung
19	chr6:32051400-32054000	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
20	chr6:32051400-32054000	Weak transcription	Duodenum Smooth Muscle	Duodenum
21	chr6:32051400-32054200	Weak transcription	Esophagus	oesophagus
22	chr6:32051600-32054000	Enhancers	Placenta Amnion	Placenta Amnion
23	chr6:32051800-32053000	Strong transcription	Brain Anterior Caudate	brain
24	chr6:32052000-32053000	Bivalent/Poised TSS	Foreskin Melanocyte Primary Cells skin01	Skin
25	chr6:32052000-32053000	Strong transcription	Spleen	Spleen
26	chr6:32052000-32053200	Strong transcription	Adipose Nuclei	Adipose
27	chr6:32052000-32054400	Weak transcription	Right Ventricle	heart
28	chr6:32052200-32054000	Weak transcription	NHDF-Ad	bronchial
29	chr6:32052200-32054200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
30	chr6:32052200-32054400	Strong transcription	Fetal Muscle Leg	muscle
31	chr6:32052200-32056400	Bivalent Enhancer	Placenta	Placenta
32	chr6:32052400-32053800	Strong transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
33	chr6:32052400-32053800	Weak transcription	Ovary	ovary
34	chr6:32052400-32054200	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
35	chr6:32052600-32053800	Weak transcription	Hela-S3	cervix
36	chr6:32052600-32053800	Weak transcription	K562	blood
37	chr6:32052600-32054600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
38	chr6:32052800-32053000	Strong transcription	Gastric	stomach
39	chr6:32052800-32053200	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
40	chr6:32052800-32054800	Weak transcription	Lung	lung
41	chr6:32053000-32053200	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
42	chr6:32053000-32053200	Bivalent Enhancer	Primary mononuclear cells fromperipheralblood	Blood
43	chr6:32053000-32053200	Genic enhancers	Fetal Intestine Small	intestine
44	chr6:32053000-32053600	Genic enhancers	Gastric	stomach
45	chr6:32053000-32054200	Weak transcription	Brain Anterior Caudate	brain
46	chr6:32053000-32054200	Weak transcription	Spleen	Spleen
47	chr6:32053200-32053400	Bivalent Enhancer	Fetal Brain Female	brain
48	chr6:32053200-32053400	Enhancers	Rectal Smooth Muscle	rectum
49	chr6:32053200-32053800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
50	chr6:32053200-32054200	Weak transcription	Adipose Nuclei	Adipose

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links